-
Something wrong with this record ?
The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey
D. Gabčová, B. Vohnout, D. Staníková, M. Hučková, M. Kadurová, M. Debreová, M. Kozárová, Ľ. Fábryová, J. Staník, I. Klimeš, K. Rašlová, D. Gašperiková
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Adult MeSH
- Hyperlipoproteinemia Type II diagnosis epidemiology genetics MeSH
- Real-Time Polymerase Chain Reaction methods MeSH
- Receptors, LDL genetics MeSH
- Humans MeSH
- Young Adult MeSH
- Statistics as Topic methods MeSH
- Health Surveys * methods MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Slovakia epidemiology MeSH
Familial hypercholesterolemia (FH) is most frequently caused by LDLR or APOB mutations. Therefore, the aim of our study was to examine the genetic background of Slovak patients suspected of FH. Patients with clinical suspicion of FH (235 unrelated probands and 124 family relatives) were recruited throughout Slovakia during the years 2011-2015. The order of DNA analyses in probands was as follows: 1. APOB mutation p.Arg3527Gln by real-time PCR method, 2. direct sequencing of the LDLR gene 3. MLPA analysis of the LDLR gene. We have identified 14 probands and 2 relatives with an APOB mutation p.Arg3527Gln, and 89 probands and 75 relatives with 54 different LDLR mutations. Nine of LDLR mutations were novel (i.e. p.Asp90Glu, c.314-2A>G, p.Asp136Tyr, p.Ser177Pro, p.Lys225_Glu228delinsCysLys, p.Gly478Glu, p.Gly675Trpfs*42, p.Leu680Pro, p.Thr832Argfs*3). This is the first study on molecular genetics of FH in Slovakia encompassing the analysis of whole LDLR gene. Genetic etiology of FH was confirmed in 103 probands (43.8 %). Out of them, 86.4 % of probands carried the LDLR gene mutation and remaining 13.6 % probands carried the p.Arg3527Gln APOB mutation.
1st Department of Pediatrics Medical Faculty of Comenius University Bratislava Slovakia
Institute of Nutrition FOZOS Slovak Medical University Bratislava Slovakia
Metabol Klinik Bratislava Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17026013
- 003
- CZ-PrNML
- 005
- 20200715133759.0
- 007
- ta
- 008
- 170824s2017 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933348 $2 doi
- 035 __
- $a (PubMed)27824480
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Gabčová, D. $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia $7 _AN092808
- 245 14
- $a The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey / $c D. Gabčová, B. Vohnout, D. Staníková, M. Hučková, M. Kadurová, M. Debreová, M. Kozárová, Ľ. Fábryová, J. Staník, I. Klimeš, K. Rašlová, D. Gašperiková
- 520 9_
- $a Familial hypercholesterolemia (FH) is most frequently caused by LDLR or APOB mutations. Therefore, the aim of our study was to examine the genetic background of Slovak patients suspected of FH. Patients with clinical suspicion of FH (235 unrelated probands and 124 family relatives) were recruited throughout Slovakia during the years 2011-2015. The order of DNA analyses in probands was as follows: 1. APOB mutation p.Arg3527Gln by real-time PCR method, 2. direct sequencing of the LDLR gene 3. MLPA analysis of the LDLR gene. We have identified 14 probands and 2 relatives with an APOB mutation p.Arg3527Gln, and 89 probands and 75 relatives with 54 different LDLR mutations. Nine of LDLR mutations were novel (i.e. p.Asp90Glu, c.314-2A>G, p.Asp136Tyr, p.Ser177Pro, p.Lys225_Glu228delinsCysLys, p.Gly478Glu, p.Gly675Trpfs*42, p.Leu680Pro, p.Thr832Argfs*3). This is the first study on molecular genetics of FH in Slovakia encompassing the analysis of whole LDLR gene. Genetic etiology of FH was confirmed in 103 probands (43.8 %). Out of them, 86.4 % of probands carried the LDLR gene mutation and remaining 13.6 % probands carried the p.Arg3527Gln APOB mutation.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zdravotnické přehledy $x metody $7 D006306
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipoproteinemie typ II $x diagnóza $x epidemiologie $x genetika $7 D006938
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $x metody $7 D060888
- 650 _2
- $a LDL-receptory $x genetika $7 D011973
- 650 _2
- $a Slovenská republika $x epidemiologie $7 D018154
- 650 _2
- $a statistika jako téma $x metody $7 D013223
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vohnout, Branislav $7 xx0121651 $u Institute of Nutrition, FOZOS, Slovak Medical University, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia
- 700 1_
- $a Staníková, Daniela $7 xx0229669 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; First Department of Pediatrics, Medical Faculty of Comenius University, Bratislava, Slovakia
- 700 1_
- $a Hučková, Miloslava. $7 xx0229639 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
- 700 1_
- $a Kadurová, M. $7 _AN092809 $u Specialized Outpatient Clinic for FHLP, Poprad, Slovakia
- 700 1_
- $a Debreová, M. $7 _AN090684 $u Pediatric Endocrinology Outpatient Clinic, Poprad, Slovakia
- 700 1_
- $a Kozárová, Miriam $7 xx0306259 $u Pediatric Endocrinology Outpatient Clinic, Poprad, Slovakia
- 700 1_
- $a Fábryová, Ľubomíra $7 xx0072891 $u Metabol Klinik, Bratislava, Slovakia
- 700 1_
- $a Staník, Juraj $7 xx0141427 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
- 700 1_
- $a Klimeš, Iwar, $d 1951- $7 xx0105928 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia; Center for Pediatric Research Leipzig, Hospital for Chil dren & Adolescents, University of Leipzig, Germany
- 700 1_
- $a Rašlová, Katarína $7 xx0072890 $u Institute of Nutrition, FOZOS, Slovak Medical University, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia
- 700 1_
- $a Gašperíková, Daniela $7 xx0229628 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia;
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 1 (2017), s. 75-84
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170824 $b ABA008
- 991 __
- $a 20200715133756 $b ABA008
- 999 __
- $a ok $b bmc $g 1246211 $s 986961
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 66 $c 1 $d 75-84 $e 20161108 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20170824